Ōtawara

Start of Clinical Research with Hiroshima University on Photon-Counting CT

Retrieved on: 
Tuesday, April 9, 2024
Biomedicine, X-ray, Congress, Medicine, Ōtawara, Medical imaging, Research, Canon Medical Systems Corporation, Society, Deep learning, Outline of health sciences, Hiroshima University

Tustin, California, April 09, 2024 (GLOBE NEWSWIRE) -- Canon Medical Systems Corporation (hereinafter "Canon Medical"; President and CEO: Toshio Takiguchi; headquarters: Otawara, Tochigi, Japan) and Hiroshima University (President: Mitsuo Ochi; location: Higashi-Hiroshima, Hiroshima, Japan) began clinical research.

Key Points: 
  • Tustin, California, April 09, 2024 (GLOBE NEWSWIRE) -- Canon Medical Systems Corporation (hereinafter "Canon Medical"; President and CEO: Toshio Takiguchi; headquarters: Otawara, Tochigi, Japan) and Hiroshima University (President: Mitsuo Ochi; location: Higashi-Hiroshima, Hiroshima, Japan) began clinical research.
  • PCCT is expected to become the next generation of X-ray CT.
    Canon Medical entered into a basic agreement on joint clinical research with Hiroshima University on November 1, 2023, *1 and clinical research began, led by Professor Kazuo Awai of the Department of Diagnostic Radiology at Hiroshima University Graduate School of Biomedical and Health Sciences.
  • Through this latest clinical research, we are aiming to take another step forward towards the practical application of PCCT.
  • We will accelerate development of PCCT by feeding back the results of this clinical research into improvement of the system.